div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails6jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails7jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails8jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=9Page 9button div class=ts-imageimg data-url=-currently-the-food-and-drug-administration-fda-requires-the-demonstrationhtmlpage=9 data-page=9 class=ts-thumb lazyload alt=Page 9: Currently the Food and Drug Administration FDA requires the demonstration of bioequivalence of generic drugs to innovator drugs in normal healthy subjects a criterion that may loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421165e93b2d1fe2026340c31a1d9html5thumbnails9jpg width=140 height=200 divdiv
